Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 21st:
OptimizeRx OPRX: This company which provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.4% over the last 60 days.

OptimizeRx Corp. price-consensus-chart | OptimizeRx Corp. Quote
OptimizeRx's shares gained 33.4% over the last three month compared with the S&P 500’s gain of 9.5%. The company possesses a Momentum Score of A.

OptimizeRx Corp. price | OptimizeRx Corp. Quote
Kanzhun BZ: This company which provides an online recruitment platform principally in China, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

KANZHUN LIMITED Sponsored ADR price-consensus-chart | KANZHUN LIMITED Sponsored ADR Quote
Kanzhun’s shares gained 23.3% over the last three month compared with the S&P 500’s gain of 9.5%. The company possesses a Momentum Score of A.

KANZHUN LIMITED Sponsored ADR price | KANZHUN LIMITED Sponsored ADR Quote
Arista Networks ANET: This company which is engaged in providing cloud networking solutions for data centers and cloud computing environments, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 60 days.

Arista Networks, Inc. price-consensus-chart | Arista Networks, Inc. Quote
Arista Networks’ shares gained 42.2% over the last three month compared with the S&P 500’s gain of 9.5%. The company possesses a Momentum Score of A.

Arista Networks, Inc. price | Arista Networks, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Sep-23 | |
| Sep-22 | |
| Sep-22 | |
| Sep-22 | |
| Sep-22 | |
| Sep-21 | |
| Sep-18 | |
| Sep-18 | |
| Sep-17 | |
| Sep-17 | |
| Sep-16 | |
| Sep-16 | |
| Sep-16 | |
| Sep-15 | |
| Sep-15 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite